Alex Lyon, MA, BM BCh, PhD, FRCP, is a Senior Lecturer in Cardiology at Imperial College, London, UK, and a Consultant Cardiologist at the Royal Brompton Hospital, London, UK. Additionaly, Dr Lyon is the Lead for Heart Failure Research and Clinical Lead for Cardio-Oncology Services at the Royal Brompton Hospital, the Chair of the UK Cardio-Oncology Consortium, and a member of the HFA Translational Research Committee (European Society of Cardiology).
Dr Lyon graduated from the University of Oxford, Oxford, UK, in 1995 with a degree in medicine, and trained as a junior doctor at the Royal Brompton Hospital. He then completed a PhD at the Mount Sinai School of Medicine, New York, NY, before being appointed Walport Clinical Lecturer in Cardiology at Imperial College, and completing his specialty training at St. Mary’s Hospital, London, UK, and the Royal Brompton Hospital. During his career, Dr Lyon has authored and co-authored over 150 peer reviewed research papers.
Speaking on cardio-oncology and cardiac complications of cancer therapies
Dr Lyon’s recent research in the hematology field focusses on the cardiac effects of anti-cancer treatments, such as anthracyclines and trastuzumab, as well as other areas of cardio-oncology, such as chemotherapy cardiomyopathy.